Key result
The tumor-to-normal ratio of ANGPTL2 mRNA levels was significantly higher in lymph node metastasis-positive non-small cell lung cancer cases (2.173) compared with metastasis-negative cases (1.212).
Why the study?
Does ANGPTL2 gene expression correlate with lymph node metastasis and survival in patients with surgically resected NSCLC?
Population
110 surgically resected non-small cell lung cancer (NSCLC) cases, mean age 66.7, 63.6% male, from Japan.
Comparison
Measurement of ANGPTL2 mRNA expression by RT-PCR vs Adjacent normal lung tissues and lymph node…
Design
Cohort
Follow-up
Follow up until August 31, 2011
Authors
Loading...
ANGPTL2 ratio associates with lymph node metastasis in resected NSCLC; leaves open survival link and clinical utility pending validation.
Observational (n=110)
No
Does ANGPTL2 gene expression correlate with lymph node metastasis and survival in patients with surgically resected NSCLC?
Absolute Event Rate: 2.173% vs 1.212%
p-value: p=0.0464
ANGPTL2 mRNA expression is significantly elevated in NSCLC with lymph node metastasis, suggesting it may play a role in the metastatic process, though it did not correlate with overall survival.
Sasaki et al. (2012) conducted an observational in Non-small cell lung cancer (NSCLC) (n=110). Lymph node metastasis vs. No lymph node metastasis was evaluated on Tumor/normal (T/N) ratio of ANGPTL2/β-actin mRNA levels (p=0.0464). The tumor-to-normal ratio of ANGPTL2 mRNA levels was significantly higher in lymph node metastasis-positive non-small cell lung cancer cases (2.173) compared with metastasis-negative cases (1.212).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: